Potential drug target for bone marrow cancer - Health Europa

New research finds patients with a rare type of bone marrow cancer have distinctive epigenetic changes that can activate harmful genes.

Chronic myelomonocytic leukaemia, a type of bone marrow cancer, develops slowly and can form when there are too many monocytes, a variation of white blood cells, in the blood. However, patients with … [+3337 chars]

full article...